Monthly Archives: September 2010

Making a Market in Antipsychotic Drugs: An Ironic Tragedy

Remember not so long ago when Prozac became the world’s largest selling medication of any kind, and then for years how Prozac, Paxil and Zoloft took over many of the top 10 spots? Remember the explanations at the time–that they were wonder drugs and that 15-50 percent or more of Americans would need them some time in their lives? To many people this seemed like a scientific breakthrough when in reality it was … a triumph of marketing.

PTSD and Anti-Depressant Drugs: the Worst Notorious Modern Medical Fraud

Some even cause worse depression and even suicide. The main side effects are nausea, insomnia, anxiety, restlessness, decreased sex drive, dizziness, weight gain or loss, tremors, sweating, sleepiness, fatigue, dry mouth, diarrhea, constipation, headache, et cetera. Who needs that stuff?!? They also screw up ones head and balance with falls and fractures. If one stops taking them, the withdrawal symptoms sound worse than heroin. In addition to all this, some are addicting and it is very difficult to stop taking them.

J&J pleads guilty to illegal marketing of psychiatric drugs

A subsidiary of pharmaceutical giant Johnson & Johnson (J&J) has pleaded guilty in federal court to misdemeanor charges of marketing a drug for unapproved uses. The guilty plea comes as part of a larger, $81-million settlement signed by J&J to settle government allegations that it illegally marketed its anti-seizure drug Topamax for the treatment of conditions including bipolar disorder and drug and alcohol addiction.

Stop the Stigma of Mental Illness? Try Stopping the Pharma Funded Campaigns & Groups Behind the “Stigmatizing”

With a seemingly altruistic agenda, the fact is the campaign to end the “stigma” of mental illness is one driven and funded by pharma, psychiatry and pharmaceutical front groups such as NAMI and CHADD to name but a few. For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill—the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs.